Cargando…

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to coronavirus disease 2019 (COVID-19) which, in turn, may be associated with multiple organ dysfunction. In this review, we present advantages and disadvantages of cannabidiol (CBD), a non-intoxicating phytocannabinoid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malinowska, Barbara, Baranowska-Kuczko, Marta, Kicman, Aleksandra, Schlicker, Eberhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922403/ https://www.ncbi.nlm.nih.gov/pubmed/33671463 http://dx.doi.org/10.3390/ijms22041986

Ejemplares similares

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
por: Mińczuk, Krzysztof, et al.
Publicado: (2022)

Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Relaxation of human pulmonary arteries by PPARγ agonists
por: Kozłowska, Hanna, et al.
Publicado: (2013)

CB(1) receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission
por: Grzęda, Emilia, et al.
Publicado: (2016)

Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2014)

Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries
por: Kozłowska, Hanna, et al.
Publicado: (2022)

Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT(3) Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
por: Kossakowski, Rafał, et al.
Publicado: (2019)

Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
por: Krzyżewska, Anna, et al.
Publicado: (2022)

Polypharmacology: promises and new drugs in 2022
por: Ryszkiewicz, Piotr, et al.
Publicado: (2023)

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
por: Kicman, Aleksandra, et al.
Publicado: (2020)

Suicidality and Cannabidiol: Opportunities and Challenges
por: Moazen-Zadeh, Ehsan, et al.
Publicado: (2021)

Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension
por: Krzyżewska, Anna, et al.
Publicado: (2021)

Current Challenges and Opportunities for Improved Cannabidiol Solubility
por: Hossain, Khondker Rufaka, et al.
Publicado: (2023)

Cross-Talk between CB(1), AT(1), AT(2) and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive Controls
por: Mińczuk, Krzysztof, et al.
Publicado: (2022)

Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
por: Remiszewski, Patryk, et al.
Publicado: (2020)

Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Integrating emerging technologies into COVID-19 contact tracing: Opportunities, challenges and pitfalls
por: Mbunge, Elliot
Publicado: (2020)

Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2022)

Cannabinoids in arterial, pulmonary and portal hypertension – mechanisms of action and potential therapeutic significance
por: Malinowska, Barbara, et al.
Publicado: (2018)

Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
por: Weresa, Jolanta, et al.
Publicado: (2022)

Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities
por: Liguori, Sara, et al.
Publicado: (2021)

In vitro human gut microbiota fermentation models: opportunities, challenges, and pitfalls
por: Isenring, Julia, et al.
Publicado: (2023)

The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension
por: Biernacki, Michał, et al.
Publicado: (2020)

Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis
por: Toczek, Marek, et al.
Publicado: (2023)

Effects of the peripheral CB(1) receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
por: Remiszewski, Patryk, et al.
Publicado: (2022)

Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls
por: Scholtes, V.P.W, et al.
Publicado: (2011)

Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations
por: Niedbała, Marcin, et al.
Publicado: (2022)

6.3 EEG AS A TOOL FOR PSYCHOSIS RESEARCH: CHALLENGES, PITFALLS AND NEW OPPORTUNITIES
por: Mulert, Christoph
Publicado: (2018)

The potential of cannabidiol in the COVID‐19 pandemic
por: Esposito, Giuseppe, et al.
Publicado: (2020)

Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol
por: Zielińska, Aleksandra, et al.
Publicado: (2022)

COVID-19: challenges and opportunities
por: Singer, Adam J, et al.
Publicado: (2020)

A Journey on the Skin Microbiome: Pitfalls and Opportunities
por: Pistone, Dario, et al.
Publicado: (2021)

Practical and Ethical Considerations in Telehealth: Pitfalls and Opportunities
por: Hull, Sarah C., et al.
Publicado: (2022)

The reproducibility of COVID-19 data analysis: paradoxes, pitfalls, and future challenges
por: Serio, Clelia Di, et al.
Publicado: (2022)

Drug-Drug Interactions Between Cannabidiol and Lithium
por: Singh, Rani K., et al.
Publicado: (2020)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Drug-drug cocrystals: Opportunities and challenges
por: Wang, Xiaojuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ro7m7ajtc09idt5h4lt21b16dq